Literature DB >> 7418261

IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.

R P Hall, T J Lawley, J A Heck, S I Katz.   

Abstract

The sera of patients with dermatitis herpetiformis, Henoch-Schönlein purpura and systemic lupus erythematosus were examined for IgA-containing immune complexes using a newly described radioimmunoassay. The IgG Raji cell radioimmunoassay and the 125I-C1q binding assay were also used to detect IgG- and IgM- containing soluble immune complexes. IgA-containing immune complexes were found in the sera of twelve of forty-nine (24%) patients with dermatitis herpetiformis, four of six (67%) patients with Henoch-Schönlein purpura, and seven of ten (70%) patients with systemic lupus erythematosus. IgG- or IgM- containing immune complexes were also found in six of forty-seven patients with dermatitis herpetiformis, in one of six patients with Henoch-Schönlein purpura, and in nine of ten patients with systemic lupus erythematosus, by either the 125I-Clq binding assay or the IgG Raji cell assay. The finding of soluble IgA immune complexes in a high percentage of patients with systemic lupus erythematosus and Henoch-Schönlein purpura suggests that they may play an important role in the pathogenesis of these diseases. In contrast, their low prevalence in patients with dermatitis herpetiformis suggests that IgA-containing immune complexes may not play a major role in the pathogenesis of dermatitis herpetiformis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418261      PMCID: PMC1538929     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schönlein syndrome.

Authors:  E H Faille-Kuyber; L Kater; C J Kooiker; E J Dorhout Mees
Journal:  Lancet       Date:  1973-04-21       Impact factor: 79.321

2.  Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

Authors:  N Rothfield; H A Ross; J O Minta; I H Lepow
Journal:  N Engl J Med       Date:  1972-10-05       Impact factor: 91.245

3.  Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease.

Authors:  P P Seah; L Fry; J S Stewart; B L Chapman; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1972-03-18       Impact factor: 79.321

4.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

5.  Letter: Dermal IgA deposits in Henoch-Schönlein purpura and Berger's nephritis.

Authors:  C C Tsai; J Giangiacomo; J Zuckner
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

6.  [Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test].

Authors:  O Braun-Falco; C Männel; R Scherer
Journal:  Hautarzt       Date:  1977-12       Impact factor: 0.751

7.  Effect of sulfones on complement deposition in dermatitis herpetiformis and on complement-mediated guinea-pig reactions.

Authors:  S I Katz; K C Hertz; P S Crawford; L A Gazze; M M Frank; T J Lawley
Journal:  J Invest Dermatol       Date:  1976-12       Impact factor: 8.551

8.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

9.  Studies of cryoproteins in systemic lupus erythematosus.

Authors:  L B Hanauer; C L Christian
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

10.  Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.

Authors:  A N Theofilopoulos; F J Dixon; V A Bokisch
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  23 in total

1.  Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura.

Authors:  F Mollica; S Li Volti; R Garozzo; G Russo
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

Review 2.  The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.

Authors:  J F Knight
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.

Authors:  C Huber; A Rüger; M Herrmann; F Krapf; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

4.  Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome.

Authors:  T A Gaither; J I Gallin; K Iida; V Nussenzweig; M M Frank
Journal:  Inflammation       Date:  1984-12       Impact factor: 4.092

Review 5.  The pathophysiology of IgA nephropathy.

Authors:  Hitoshi Suzuki; Krzysztof Kiryluk; Jan Novak; Zina Moldoveanu; Andrew B Herr; Matthew B Renfrow; Robert J Wyatt; Francesco Scolari; Jiri Mestecky; Ali G Gharavi; Bruce A Julian
Journal:  J Am Soc Nephrol       Date:  2011-09-23       Impact factor: 10.121

6.  Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells.

Authors:  G Herrero-Beaumont; J Egido; J Sancho; E González; S Castañeda; J F Escanero
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

7.  Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.

Authors:  J H Galla; M F Spotswood; L A Harrison; J Mestecky
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

8.  Dermatitis herpetiformis: effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity.

Authors:  J A Kazmierowski; J E Ross; D S Peizner; K D Wuepper
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

9.  IgA containing immune complexes in dogs bearing a spontaneous mammary adenocarcinoma.

Authors:  J Balint; T Nagai; Y Ikeda; K Meek; D S Terman
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

10.  Dermatitis herpetiformis: relation between circulating immune complexes, small-intestinal mucosal status, and immunohistopathological findings.

Authors:  E Szabó; S Husz; T Várkonyi; Z F Kiss
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.